Memory and synaptic deficits in Hip14/DHHC17 knockout mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 50, 2013, Pages 20296-20301

  Milnerwood, Austen J ^a,b   Parsons, Matthew P ^a,b   Young, Fiona B ^a   Singaraja, Roshni R ^a   Franciosi, Sonia ^a   Volta, Mattia ^a   Bergeron, Sabrina ^a   Hayden, Michael R ^a   Raymond, Lynn A ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Hippocampus; Huntington disease; Long term potentiation; Posttranslational modification; Striatum

Indexed keywords

HUNTINGTIN INTERACTING PROTEIN 14; PROTEIN; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; LONG TERM POTENTIATION; MALE; MEMORY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; SYNAPSE;

EID: 84890283091     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1222384110     Document Type: Article

References (48)

1. el-Husseini Ael-D, Bredt DS (2002) Protein palmitoylation: A regulator of neuronal development and function. Nat Rev Neurosci 3(10):791-802.
2. Fukata Y, Fukata M (2010) Protein palmitoylation in neuronal development and synaptic plasticity. Nat Rev Neurosci 11(3):161-175.
3. El-Husseini Ael-D, et al. (2002) Synaptic strength regulated by palmitate cycling on PSD-95. Cell 108(6):849-863.
4. Ho GP, et al. (2011) S-nitrosylation and S-palmitoylation reciprocally regulate synaptic targeting of PSD-95. Neuron 71(1):131-141.
5. Craven SE, El-Husseini AE, Bredt DS (1999) Synaptic targeting of the postsynaptic density protein PSD-95 mediated by lipid and protein motifs. Neuron 22(3):497-509.
6. Yang G, Xiong W, Kojic L, Cynader MS (2009) Subunit-selective palmitoylation regulates the intracellular trafficking of AMPA receptor. Eur J Neurosci 30(1):35-46.
7. Lin DT, et al. (2009) Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation. Nat Neurosci 12(7):879-887.
8. Gladding CM, Raymond LA (2011) Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function. Mol Cell Neurosci 48(4):308-320.
9. Hayashi T, Thomas GM, Huganir RL (2009) Dual palmitoylation of NR2 subunits regulates NMDA receptor trafficking. Neuron 64(2):213-226.
10. Young FB, Butland SL, Sanders SS, Sutton LM, Hayden MR (2012) Putting proteins in their place: Palmitoylation in Huntington disease and other neuropsychiatric diseases. Prog Neurobiol 97(2):220-238.
11. Singaraja RR, et al. (2011) Altered palmitoylation and neuropathological deficits in mice lacking HIP14. Hum Mol Genet 20(20):3899-3909.
12. Huang K, et al. (2004) Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron 44(6):977-986.
13. Huang K, et al. (2009) Neuronal palmitoyl acyl transferases exhibit distinct substrate specificity. FASEB J 23(8):2605-2615.
14. Ohyama T, et al. (2007) Huntingtin-interacting protein 14, a palmitoyl transferase required for exocytosis and targeting of CSP to synaptic vesicles. J Cell Biol 179(7):1481-1496.
15. Yanai A, et al. (2006) Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function. Nat Neurosci 9(6):824-831.
16. Huang K, et al. (2011) Wild-type HTT modulates the enzymatic activity of the neuronal palmitoyl transferase HIP14. Hum Mol Genet 20(17):3356-3365.
17. Milnerwood AJ, Raymond LA (2010) Early synaptic pathophysiology in neurodegeneration: Insights from Huntington's disease. Trends Neurosci 33(11):513-523.
18. Raymond LA, et al. (2011) Pathophysiology of Huntington's disease: Time-dependent alterations in synaptic and receptor function. Neuroscience 198(198):252-273.
19. Murphy KP, et al. (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci 20(13):5115-5123.
20. Smith R, Brundin P, Li JY (2005) Synaptic dysfunction in Huntington's disease: A new perspective. Cell Mol Life Sci 62(17):1901-1912.
21. Milnerwood AJ, et al. (2006) Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. Hum Mol Genet 15(10):1690-1703.
22. Usdin MT, Shelbourne PF, Myers RM, Madison DV (1999) Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum Mol Genet 8(5):839-846.
23. Lynch G, et al. (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J Neurosci 27(16):4424-4434.
24. Milnerwood AJ, Raymond LA (2007) Corticostriatal synaptic function in mouse models of Huntington's disease: Early effects of huntingtin repeat length and protein load. J Physiol 585(Pt 3):817-831.
25. Nisenbaum ES, Wilson CJ (1995) Potassium currents responsible for inward and outward rectification in rat neostriatal spiny projection neurons. J Neurosci 15(6):4449-4463.
26. Bindman LJ, Meyer T, Prince CA (1988) Comparison of the electrical properties of neocortical neurones in slices in vitro and in the anaesthetized rat. Exp Brain Res 69(3):489-496.
27. Thomas MJ, Beurrier C, Bonci A, Malenka RC (2001) Long-term depression in the nucleus accumbens: A neural correlate of behavioral sensitization to cocaine. Nat Neurosci 4(12):1217-1223.
28. Ehrlich I, Malinow R (2004) Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. J Neurosci 24(4):916-927.
29. Keith DJ, et al. (2012) Palmitoylation of A-kinase anchoring protein 79/150 regulates dendritic endosomal targeting and synaptic plasticity mechanisms. J Neurosci 32(21):7119-7136.
30. Milner AJ, Cummings DM, Spencer JP, Murphy KP (2004) Bi-directional plasticity and age-dependent long-term depression at mouse CA3-CA1 hippocampal synapses. Neurosci Lett 367(1):1-5.
31. Barker GR, Warburton EC (2011) When is the hippocampus involved in recognition memory? J Neurosci 31(29):10721-10731.
32. Kaufman AM, et al. (2012) Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons. J Neurosci 32(12):3992-4003.
33. Segal M, Greenberger V, Korkotian E (2003) Formation of dendritic spines in cultured striatal neurons depends on excitatory afferent activity. Eur J Neurosci 17(12):2573-2585.
34. Mattison HA, Hayashi T, Barria A (2012) Palmitoylation at two cysteine clusters on the C-terminus of GluN2A and GluN2B differentially control synaptic targeting of NMDA receptors. PLoS ONE 7(11):e49089.
35. Hayashi T, Rumbaugh G, Huganir RL (2005) Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites. Neuron 47(5):709-723.
36. Jurado S, et al. (2013) LTP requires a unique postsynaptic SNARE fusion machinery. Neuron 77(3):542-558.
37. Kang R, et al. (2008) Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation. Nature 456(7224):904-909.
38. Greaves J, Chamberlain LH (2011) DHHC palmitoyl transferases: Substrate interactions and (patho)physiology. Trends Biochem Sci 36(5):245-253.
39. Mukai J, et al. (2004) Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 36(7):725-731.
40. Li Y, et al. (2010) DHHC5 interacts with PDZ domain 3 of post-synaptic density-95 (PSD-95) protein and plays a role in learning and memory. J Biol Chem 285(17):13022-13031.
41. Raymond FL, et al. (2007) Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus. Am J Hum Genet 80(5):982-987.
42. Mansouri MR, et al. (2005) Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation. Eur J Hum Genet 13(8):970-977.
43. Simmons DA, et al. (2009) Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc Natl Acad Sci USA 106(12):4906-4911.
44. Orth M, et al. (2010) Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease. J Neurol Neurosurg Psychiatry 81(3):267-270.
45. Stout JC, et al. (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25(1):1-14.
46. Milnerwood AJ, et al. (2010) Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron 65(2):178-190.
47. Petkau TL, et al. (2012) Synaptic dysfunction in progranulin-deficient mice. Neurobiol Dis 45(2):711-722.
48. Slow EJ, et al. (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12(13):1555-1567.